Careers  |  Sign In  |  Register

Latest in Transplantation

Reuters Health • The Doctor's Channel Daily Newscast

Nitazoxanide added to treatment of hepatitis C genotype 4 improves outcome

NEW YORK (Reuters Health) – In patients with chronic hepatitis C genotype 4, adding nitazoxanide to peginterferon alfa-2a and ribavirin improves the virologic response rates, new research shows. In the study, patients treated with the three-drug combination achieved a sustained virologic response rate...
Jorge D. Reyes, MD, Director of Transplant Program, Seattle Children's Hospital and Regional Medical Center, discusses the issues surrounding CMV prophylaxis in pediatric transplant recipients. References and Resources Chong AL, Clinton F, Breatnach F, O'Marcaigh A, Butler K, O'Meara A. ...
Josh Levitsky, MD, Assistant Professor, Division of Hepatology, Northwestern University, discusses the management of patients in acute liver failure. References and Resources O'Neal H, Olds J, Webster N. Managing patients with acute liver failure: developing a tool for practitioners. Nurs Crit...